ABIVAX SA-ADR (ABVX) Stock Overview
USA - NASDAQ:ABVX - US00370M1036 - ADR
ABVX Key Statistics, Chart & Performance
The current stock price of ABVX is 82.28 USD. In the past month the price increased by 17.53%. In the past year, price increased by 628.14%.
ABVX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.42 | 382.04B | ||
| AMGN | AMGEN INC | 12.52 | 147.02B | ||
| GILD | GILEAD SCIENCES INC | 14.32 | 137.56B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.1 | 100.34B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.6 | 60.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.46B | ||
| ARGX | ARGENX SE - ADR | 81.16 | 46.04B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.71 | 38.90B | ||
| INSM | INSMED INC | N/A | 30.60B | ||
| NTRA | NATERA INC | N/A | 24.02B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.86B | ||
| BIIB | BIOGEN INC | 8.97 | 21.06B |
Related stock screener links
About ABVX
Company Profile
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 67 full-time employees. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.
Company Info
ABIVAX SA-ADR
7-11 Boulevard Haussmann
Paris ILE-DE-FRANCE FR
Employees: 69
Phone: 33153830963
ABIVAX SA-ADR / ABVX FAQ
What is the stock price of ABIVAX SA-ADR today?
The current stock price of ABVX is 82.28 USD. The price decreased by -4.18% in the last trading session.
What is the ticker symbol for ABIVAX SA-ADR stock?
The exchange symbol of ABIVAX SA-ADR is ABVX and it is listed on the Nasdaq exchange.
On which exchange is ABVX stock listed?
ABVX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ABIVAX SA-ADR stock?
13 analysts have analysed ABVX and the average price target is 111.86 USD. This implies a price increase of 35.95% is expected in the next year compared to the current price of 82.28. Check the ABIVAX SA-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ABIVAX SA-ADR worth?
ABIVAX SA-ADR (ABVX) has a market capitalization of 6.22B USD. This makes ABVX a Mid Cap stock.
How many employees does ABIVAX SA-ADR have?
ABIVAX SA-ADR (ABVX) currently has 69 employees.
What are the support and resistance levels for ABIVAX SA-ADR (ABVX) stock?
ABIVAX SA-ADR (ABVX) has a support level at 82.27. Check the full technical report for a detailed analysis of ABVX support and resistance levels.
Is ABIVAX SA-ADR (ABVX) expected to grow?
The Revenue of ABIVAX SA-ADR (ABVX) is expected to grow by 124.58% in the next year. Check the estimates tab for more information on the ABVX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ABIVAX SA-ADR (ABVX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ABVX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ABVX, evaluating the profitability, health, valuation and growth aspects
- ABIVAX SA-ADR (ABVX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ABIVAX SA-ADR (ABVX) Sales and EPS estimates to see what analysts future expectations are.
- ABIVAX SA-ADR (ABVX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ABIVAX SA-ADR (ABVX) Insider and Institutional Ownership to learn about the owners and their transactions.
- ABIVAX SA-ADR (ABVX) Stock Chart to make your own analysis
- ABIVAX SA-ADR (ABVX) Latest news and press-releases to stay up to date.
Does ABIVAX SA-ADR (ABVX) stock pay dividends?
ABVX does not pay a dividend.
When does ABIVAX SA-ADR (ABVX) report earnings?
ABIVAX SA-ADR (ABVX) will report earnings on 2025-12-15.
What is the Price/Earnings (PE) ratio of ABIVAX SA-ADR (ABVX)?
ABIVAX SA-ADR (ABVX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.77).
What is the Short Interest ratio of ABIVAX SA-ADR (ABVX) stock?
The outstanding short interest for ABIVAX SA-ADR (ABVX) is 2.26% of its float. Check the ownership tab for more information on the ABVX short interest.
ABVX Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ABVX. When comparing the yearly performance of all stocks, ABVX is one of the better performing stocks in the market, outperforming 99.79% of all stocks.
ABVX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ABVX. Both the profitability and financial health of ABVX have multiple concerns.
ABVX Financial Highlights
Over the last trailing twelve months ABVX reported a non-GAAP Earnings per Share(EPS) of -2.77. The EPS increased by 18.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -105.57% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ABVX Forecast & Estimates
13 analysts have analysed ABVX and the average price target is 111.86 USD. This implies a price increase of 35.95% is expected in the next year compared to the current price of 82.28.
For the next year, analysts expect an EPS growth of 3.43% and a revenue growth 124.58% for ABVX